Sports nutrition specialist Science in Sport which posted a ten per cent increase in its revenues to reach £32.3m for the six months to 30 June 2022, saw an underlying EBITDA loss of £2.3m as compared with a a£600k profit for the same period last year.
It has announced a £5m share placing to enable it to weather the ongoing economic ‘storms’.
“After a strong start to the year, weakening consumer demand, temporary supply chain issues and input cost increases have combined to impact our trading,” commented Stephen Moon, CEO.
In separate news, the business has appointed Daniel Lampard as its CFO effective October 19th. He joins from Unbound Group.
Share